Wellcome Sanger Institute
![Sanger Institute Science Collaboration](/wp-content/uploads/GettyImages-150666845-3.jpg)
Identification of novel drug targets in colorectal cancer.
We are using siKinome and genome-wide CRISPR/Cas9 lethality screens in colorectal cancer cell lines to identify novel vulnerabilities.
We are using siKinome and genome-wide CRISPR/Cas9 lethality screens in colorectal cancer cell lines to identify novel vulnerabilities.